1. Home
  2. AMBO vs ENLV Comparison

AMBO vs ENLV Comparison

Compare AMBO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$1.52

Market Cap

4.3M

Sector

Real Estate

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

N/A

Current Price

$1.84

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMBO
ENLV
Founded
2000
2005
Country
United States
Israel
Employees
160
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.0M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
AMBO
ENLV
Price
$1.52
$1.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1K
★ 1.7M
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 337.04
N/A
EPS
★ 0.00
N/A
Revenue
★ $9,469,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$316.35
★ N/A
Revenue Growth
★ 0.82
N/A
52 Week Low
$1.47
$0.16
52 Week High
$5.25
$7.64

Technical Indicators

Market Signals
Indicator
AMBO
ENLV
Relative Strength Index (RSI) 29.04 64.19
Support Level $1.47 $0.65
Resistance Level $2.19 $7.64
Average True Range (ATR) 0.04 0.16
MACD -0.02 0.28
Stochastic Oscillator 0.00 59.71

Price Performance

Historical Comparison
AMBO
ENLV

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: